Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes

References

• Sun Y, An N, Li J, et al. miRNA-206 regulates human pulmonary microvascular endothelial cell apoptosis via targeting in chronic obstructive pulmonary disease. J Cell Biochem. 2019;120(4):6223–6236.
   PubMed Web of Science ®Google Scholar
• Xia J, Zhang H, Guan Q, et al. Qualitative diagnostic signature for pancreatic ductal adenocarcinoma based on the within-sample relative expression orderings. J Gastroenterol Hepatol. 2021;36(6):1714–1720.
   PubMed Web of Science ®Google Scholar
• Mao J, Li Y, Li S, et al. Bufei Jianpi granules reduce quadriceps muscular cell apoptosis by improving mitochondrial function in rats with chronic obstructive pulmonary disease. Evid Based Complement Alternat Med. 2019;2019:1–9.
   Web of Science ®Google Scholar
• Ma J, Tian Y, Li J, et al. Effect of Bufei Yishen granules combined with electroacupuncture in rats with chronic obstructive pulmonary disease via the regulation of TLR-4/NF-kappaB signaling. Evid Based Complement Alternat Med. 2019;2019:6708645.
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717.
   PubMed Web of Science ®Google Scholar
• Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458.
   PubMed Web of Science ®Google Scholar
• Sandri BJ, Kaplan A, Hodgson SW, et al. Multi-omic molecular profiling of lung cancer in COPD. Eur Respir J. 2018;52(1):1702665.
   PubMed Web of Science ®Google Scholar
• Xia R, Tang H, Shen J, et al. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population. Cancer Cell Int. 2021;21(1):154.
   PubMed Web of Science ®Google Scholar
• Wang X. New biomarkers and therapeutics can be discovered during COPD-lung cancer transition. Cell Biol Toxicol. 2016;32(5):359–361.
   PubMed Web of Science ®Google Scholar
• Zhao P, Yang L, Li J, et al. Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese Herbal Bufei Jianpi formula for application to COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:553–566.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao P, Yang L, et al. System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling. Sci Rep. 2016;6:25492.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao P, Tian Y, et al. Systems pharmacology-based dissection of the active ingredients and targets of Yiqi Zishen formula for application to COPD. Int J Clin Exp Med. 2017;10(8):12825–12844.
   Web of Science ®Google Scholar
• Li SY, Li JS, Wang MH, et al. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med. 2012;12:197.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao P, Li Y, et al. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease. Sci Rep. 2015;5:15290.
   PubMed Web of Science ®Google Scholar
• Zhao P, Li J, Li Y, et al. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese Herbal Bufei Jianpi formula for the treatment of COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:2633–2656.
   PubMed Web of Science ®Google Scholar
• Zhao P, Li J, Li Y, et al. Integrating transcriptomics, proteomics, and metabolomics profiling with system pharmacology for the delineation of long-term therapeutic mechanisms of Bufei Jianpi formula in treating COPD. Biomed Res Int. 2017;2017:7091087.
   PubMed Web of Science ®Google Scholar
• Dong H, Liu X, Zheng W, et al. Three Tiaobu Feishen formulae reduces cigarette smoke-induced inflammation in human airway epithelial cells. J Tradit Chin Med. 2020;40(3):386–392.
   PubMed Web of Science ®Google Scholar
• Li C, Long Q, Zhang D, et al. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma. BMC Cancer. 2020;20(1):1198.
   PubMed Web of Science ®Google Scholar
• Shen C, Liu J, Wang L, et al. Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer. Cancer Cell Int. 2020;20(1):538.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhu K, Pu H, et al. An immune-related signature predicts survival in patients with lung adenocarcinoma. Front Oncol. 2019;9:1314.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen J, Yang H, et al. Multiple microarray analyses identify key genes associated with the development of non-small cell lung cancer from chronic obstructive pulmonary disease. J Cancer. 2021;12(4):996–1010.
   PubMed Web of Science ®Google Scholar
• Guan Q, Zeng Q, Yan H, et al. A qualitative transcriptional signature for the early diagnosis of colorectal cancer. Cancer Sci. 2019;110(10):3225–3234.
   PubMed Web of Science ®Google Scholar
• Guan Q, Zhang J, Guo Y, et al. The effects of age, cigarette smoking, sex, and race on the qualitative characteristics of lung transcriptome. Biomed Res Int. 2020;2020:1–7.
   Web of Science ®Google Scholar
• He J, Cheng J, Guan Q, et al. Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy. Cancer Sci. 2020;111(1):253–265.
   PubMed Web of Science ®Google Scholar
• Zhang ZM, Wang JS, Zulfiqar H, et al. Early diagnosis of pancreatic ductal adenocarcinoma by combining relative expression orderings with machine-learning method. Front Cell Dev Biol. 2020;8:582864.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao P, Yang L, et al. Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations. Biosci Rep. 2017;37(3):BSR20170042.
   Google Scholar
• Li Y, Li SY, Li JS, et al. A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection. Biol Pharm Bull. 2012;35(10):1752–1760.
   PubMed Web of Science ®Google Scholar
• Li Y, Tian YG, Li JS, et al. Bufei Yishen granules combined with acupoint sticking therapy suppress oxidative stress in chronic obstructive pulmonary disease rats: via regulating peroxisome proliferator-activated receptor-gamma signaling. J Ethnopharmacol. 2016;193:354–361.
   PubMed Web of Science ®Google Scholar
• Mao J, Li Y, Feng S, et al. Bufei Jianpi formula improves mitochondrial function and suppresses mitophagy in skeletal muscle via the adenosine monophosphate-activated protein kinase pathway in chronic obstructive pulmonary disease. Front Pharmacol. 2020;11:587176.
   PubMed Web of Science ®Google Scholar
• Zhao P, Liu X, Dong H, et al. Bufei Yishen formula restores Th17/Treg balance and attenuates chronic obstructive pulmonary disease via activation of the adenosine 2a receptor. Front Pharmacol. 2020;11:1212.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27–30.
   PubMed Web of Science ®Google Scholar
• Lee KY, Ho SC, Chan YF, et al. Reduced nuclear factor-kappaB repressing factor: a link toward systemic inflammation in COPD. Eur Respir J. 2012;40(4):863–873.
   PubMed Web of Science ®Google Scholar
• Tanrikulu AC, Abakay A, Evliyaoglu O, et al. Coenzyme Q10, copper, zinc, and lipid peroxidation levels in serum of patients with chronic obstructive pulmonary disease. Biol Trace Elem Res. 2011;143(2):659–667.
   PubMed Web of Science ®Google Scholar
• Marinari S, Manigrasso MR, De Benedetto F. Effects of nutraceutical diet integration, with coenzyme Q10 (Q-Ter multicomposite) and creatine, on dyspnea, exercise tolerance, and quality of life in COPD patients with chronic respiratory failure. Multidiscip Respir Med. 2013;8(1):40.
   PubMedGoogle Scholar
• Schiffelers SL, Blaak EE, Baarends EM, et al. Beta-adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab. 2001;280(2):357–364.
   Web of Science ®Google Scholar
• Mudunuri U, Che A, Yi M, et al. bioDBnet: the biological database network. Bioinformatics. 2009;25(4):555–556.
   PubMed Web of Science ®Google Scholar
• Zong D, Ouyang R, Li J, et al. Notch signaling in lung diseases: focus on Notch1 and Notch3. Ther Adv Respir Dis. 2016;10(5):468–484.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu Y, Miao X, et al. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in non-Hodgkin’s lymphoma. Int J Biol Macromol. 2015;81:809–817.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Chujo M, Moroga T, et al. DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer. Anticancer Res. 2009;29(7):2753–2757.
   PubMed Web of Science ®Google Scholar
• Meng F, Zhang L, Ren Y, et al. Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer. Cancer Biomark. 2020;29(4):475–482.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Z, Yu Z. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. J Transl Med. 2019;17(1):423.
   PubMed Web of Science ®Google Scholar
• Guan Q, Zeng Q, Jiang W, et al. A qualitative transcriptional signature for the risk assessment of precancerous colorectal lesions. Front Genet. 2020;11:573787.
   PubMed Web of Science ®Google Scholar
• Bodas M, Subramaniyan B, Moore AR, et al. The NOTCH3 downstream target HEYL is required for efficient human airway basal cell differentiation. Cells. 2021;10(11):3215.
   PubMed Web of Science ®Google Scholar
• Shi C, Qian J, Ma M, et al. Notch 3 protein, not its gene polymorphism, is associated with the chemotherapy response and prognosis of advanced NSCLC patients. Cell Physiol Biochem. 2014;34(3):743–752.
   PubMedGoogle Scholar
• Ma Y, Li M, Si J, et al. Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer. Int J Oncol. 2016;48(6):2349–2358.
   PubMed Web of Science ®Google Scholar
• Kalathiya U, Padariya M, Pawlicka K, et al. Insights into the effects of cancer associated mutations at the UPF2 and ATP-binding sites of NMD master regulator: UPF1. Int J Mol Sci. 2019;20(22):5644.
   PubMed Web of Science ®Google Scholar
• Rao S, Amorim R, Niu M, et al. The RNA surveillance proteins UPF1, UPF2 and SMG6 affect HIV-1 reactivation at a post-transcriptional level. Retrovirology. 2018;15(1):42.
   PubMedGoogle Scholar
• Han S, Cao D, Sha J, et al. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2. Mol Oncol. 2020;14(5):1074–1088.
   PubMed Web of Science ®Google Scholar
• Pan Y, Liu H, Wang Y, et al. Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep. 2017;7:44634.
   PubMed Web of Science ®Google Scholar
• Miller CT, Aggarwal S, Lin TK, et al. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas. Cancer Res. 2003;63(14):4136–4143.
   PubMed Web of Science ®Google Scholar
• Boni J, Rubio-Perez C, Lopez-Bigas N, et al. The DYRK family of kinases in cancer: molecular functions and therapeutic opportunities. Cancers. 2020;12(8):2106.
   PubMed Web of Science ®Google Scholar
• Shi J, Chen Y, Wang Z, et al. Comprehensive bioinformatics analysis to identify the gene HMMR associated with lung adenocarcinoma prognosis and its mechanism of action in multiple cancers. Front Oncol. 2021;11:712795.
   PubMed Web of Science ®Google Scholar
• Jiang X, Tang L, Yuan Y, et al. NcRNA-mediated high expression of HMMR as a prognostic biomarker correlated with cell proliferation and cell migration in lung adenocarcinoma. Front Oncol. 2022;12:846536.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shen L, Chen B, et al. The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer. Ann Transl Med. 2021;9(10):843.
   PubMed Web of Science ®Google Scholar
• Guan Q, Chen R, Yan H, et al. Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms. Oncotarget. 2016;7(42):68909–68920.
   PubMedGoogle Scholar
• Zhou YJ, Lu XF, Meng JL, et al. Qualitative transcriptional signature for the pathological diagnosis of pancreatic cancer. Front Mol Biosci. 2020;7:569842.
   PubMed Web of Science ®Google Scholar
• Cheng J, Guo Y, Gao Q, et al. Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites. Oncotarget. 2017;8(18):30265–30275.
   PubMedGoogle Scholar
• Chen R, Guan Q, Cheng J, et al. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples. Oncotarget. 2017;8(4):6652–6662.
   PubMedGoogle Scholar
• Liu H, Li Y, He J, et al. Robust transcriptional signatures for low-input RNA samples based on relative expression orderings. BMC Genomics. 2017;18(1):913.
   PubMedGoogle Scholar